Author

L. Marchetti

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 2 Biophysics· 1 Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Organism:human· 2 Organism:mouse· 2 Research Focus:cell-cell communication· 1 Research Focus:chromatin & epigenetic regulation· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Organism:E. coli· 1

Frequent Co-Authors

A. Ariga· 1 shared A. Buchamer· 1 shared A. Carranza· 1 shared A. Cattaneo· 1 shared A. Fochesato· 1 shared A. Kuzmanic· 1 shared A. Mossu· 1 shared A. Novelli· 1 shared

Activity by Year

2018-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 7 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Ariga

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

stormTB: A web-based simulator of a murine minimal-PBPK model for anti-tuberculosis treatments.

R. Visintainer, A. Fochesato, D. Boaretti, S. Giampiccolo, S. Watson, M. Levi, F. Reali, L. Marchetti

stormTB provides a web-based mPBPK model for simulating anti-TB drug treatments in mice, enabling pharmacokinetic comparisons and supporting 11 drugs.

bioRxiv · Jul 4, 2024Pharmacology & Toxicology

Genomic epidemiology of third-generation cephalosporin-resistant Escherichia coli from Argentinian pig and dairy farms reveals animal-specific patterns of co-resistance and resistance mechanisms

O. Mounsey, L. Marchetti, J. Parada, L. V. Alarcon, F. Aliverti, M. B. Avison, C. S. Ayala, C. Ballesteros, C. M. Best, J. Bettridge, A. Buchamer, D. Buldain, A. Carranza, M. C. Isgro, D. Demeritt, , M. Pellegrino

This study identifies animal-specific patterns of third-generation cephalosporin resistance in E. coli from Argentinian pig and dairy farms, revealing differences in resistance mechanisms and co-resistance patterns.

bioRxiv · Jun 15, 2023 · PreprintMicrobiology

UFMTrack: Under-Flow Migration Tracker enabling analysis of the entire multi-step immune cell extravasation cascade across the blood-brain barrier in microfluidic devices

M. Vladymyrov, L. Marchetti, S. Aydin, S. G. N. Soldati, A. Mossu, A. Pal, L. Gueissaz, A. Ariga, B. Engelhardt

UFMTrack automates analysis of immune cell extravasation across the BBB in microfluidic devices, achieving 90% track reconstruction efficiency and reducing experimenter bias.

bioRxiv · Jan 4, 2023Immunology

Ceftolozane-tazobactam pharmacokinetics during extracorporeal membrane oxygenation in a lung transplant recipient

F. Arena, L. Marchetti, L. Henrici De Angelis, E. Maglioni, M. Contorni, M. I. Cassetta, A. Novelli, G. Rossolini

The paper reports ceftolozane and tazobactam plasma levels in a lung transplant recipient on ECMO receiving ceftolozane-tazobactam, showing optimal drug exposure.

bioRxiv · Oct 9, 2018Pharmacology & Toxicology

The structure of the Pro-domain of mouse proNGF in contact with the NGF domain

R. Yan, H. Yalinca, F. Paoletti, F. Gobbo, L. Marchetti, A. Kuzmanic, D. Lamba, F. L. Gervasio, P. V. Konarev, A. Cattaneo, A. Pastore

This study determines the structure of the pro-domain of mouse proNGF using NMR and SAXS, revealing its intrinsic disorder and functional interactions with mature NGF.

bioRxiv · May 29, 2018Biophysics